Author

H.-C. Kornau

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 3 Assay:proteomics· 2 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Organism:mouse· 1 Approach:statistical model· 1 Assay:structural biology· 1

Frequent Co-Authors

J. Kreye· 3 shared M. Yuan· 3 shared S. M. Reincke· 3 shared C. Drosten· 2 shared C.-C. D. Lee· 2 shared D. Schmitz· 2 shared E. Sanchez-Sendin· 2 shared H. Liu· 2 shared

Activity by Year

2020-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

J. Kreye

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

SARS-CoV-2 Beta variant infection elicits potent lineage-specific and cross-reactive antibodies

S. M. Reincke, M. Yuan, H.-C. Kornau, V. M. Corman, S. van Hoof, E. Sanchez-Sendin, M. Ramberger, W. Yu, Y. Hua, H. Tien, M. L. Schmidt, T. Schwarz, L. M. Jeworowski, S. E. Brandl, H. Foverskov Rasmussen, , J. Kreye

SARS-CoV-2 Beta variant infection generates lineage-specific antibodies and cross-reactive antibodies with neutralizing activity against wild-type and other variants.

bioRxiv · Sep 30, 2021Immunology

A combination of cross-neutralizing antibodies synergizes to prevent SARS-CoV-2 and SARS-CoV pseudovirus infection

H. Liu, M. Yuan, D. Huang, S. Bangaru, C.-C. D. Lee, L. Peng, X. Zhu, D. Nemazee, M. J. van Gils, R. W. Sanders, H.-C. Kornau, S. M. Reincke, H. Pruss, J. Kreye, N. C. Wu, , I. A. Wilson

This study shows that combining cross-neutralizing antibodies CV38-142 and COVA1-16 enhances neutralization of SARS-CoV-2 and SARS-CoV pseudoviruses.

bioRxiv · Feb 11, 2021Microbiology

A SARS-CoV-2 neutralizing antibody protects from lung pathology in a COVID-19 hamster model

J. Kreye, S. M. Reincke, H.-C. Kornau, E. Sanchez-Sendin, V. M. Corman, H. Liu, M. Yuan, N. C. Wu, X. Zhu, C.-C. D. Lee, J. Trimpert, M. Hoeltje, K. Dietert, L. Stoeffler, N. von Wardenburg, , N. Osterrieder

This study identifies a potent SARS-CoV-2 neutralizing antibody that protects hamsters from infection and lung damage.

bioRxiv · Aug 15, 2020Immunology